Skip to main content

GP-Act III Acquisition Corp.

GPAT
Exchange
Nasdaq
Industry
Blank Checks
SEC CIK
0001834526

No open-market purchases or sales by GP-Act III Acquisition Corp. insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q2 2026, worth $96.2M in total; no superinvestor holds it.

Other share classesGPATUGPATW

Q1 2025 vs. Q4 2024

How the institutions holding GP-Act III Acquisition Corp. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025All holders in Q4 2024

13F holders of GPAT: Q4 2024 compared with Q1 2025
MeasureQ4 2024Q1 2025Change
Holders4240−2
Shares26.3M26.2M−151.0K (−0.6%)
Value$266.8M$269.5M+$2.74M (+1.0%)

New holders (2)

Institutions that held GP-Act III Acquisition Corp. at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to GPAT in Q1 2025
InstitutionSharesValue% of portfolio
Mizuho Securities USA LLC30,000$303.0K0.01%
Morgan Stanley32$3290.00%

Sold out (4)

Institutions that held GP-Act III Acquisition Corp. at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of GPAT in Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
Fir Tree Capital Management LP28,846$293.1K
Toroso Investments, LLC19,548$198.4K
Highbridge Capital Management LLC10,000$101.6K
Tower Research Capital LLC (TRC)120$1.22K